3 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Terminated 1 |
Follow macozinone: new trials by email Literature Review of macozinone trials Research Report on macozinone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing PBTZ169, Placebo - Tuberculosis, Pulmonary | Phase 1 | Completed | Innovative Medicines for Tuberculosis | 32 | 2019-02-21 | 2020-10-22 |
| Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169 PBTZ169 640 mg OD, PBTZ169 640 mg BiD, PBTZ169 960 mg SD - Healthy Subjects | Phase 1 | Completed | Nearmedic Plus LLC | 60 | 2018-07-03 | 2020-02-28 |
| Phase 2a Study of PBTZ169 PBTZ169, Isoniazid - Tuberculosis | Phase 2 | Terminated | Nearmedic Plus LLC | 16 | 2016-12-16 | 2020-03-09 |
| Phase 1 Study of PBTZ169 PBTZ169 - 40 mg, PBTZ169 - 80 mg, PBTZ169 - 160 mg - Tuberculosis | Phase 1 | Completed | Nearmedic Plus LLC | 40 | 2016-01-01 | 2020-04-13 |
Tuberculosis (3) · Extensively Drug-Resistant Tuberculosis (1) · Tuberculosis, Multidrug-Resistant (1) · Tuberculosis, Pulmonary (1)
Nearmedic Plus LLC (3) · Innovative Medicines for Tuberculosis (1)
Russia (1) · Switzerland (1)